{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:33:54Z","timestamp":1791851634548,"version":"4.3.4"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ando.2022.11.004","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T20:07:04Z","timestamp":1673035624000},"page":"308-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Polycystic ovary syndrome and adipose tissue"],"prefix":"10.1016","volume":"84","author":[{"given":"Madleen","family":"Lemaitre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Christin-Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Kerlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2022.11.004_bib0540","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2022.11.004_bib0545","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2022.11.004_bib0550","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycysticovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2022.11.004_bib0555","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"key":"10.1016\/j.ando.2022.11.004_bib0560","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.ando.2022.11.004_bib0565","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ando.2022.11.004_bib0570","first-page":"37","article-title":"FIGO Committee on menstrual disorders and related health im-pacts, and FIGO committee on reproductive medicine, endocrinology, and infertility. The FIGO Ovulatory Disorders Classification System","author":"Munro","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2022.11.004_bib0575","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2022.11.004_bib0580","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2009.04.021","article-title":"Not all women diagnosed with PCOS share the same cardiovascular risk profiles","volume":"94","author":"Jovanovic","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2022.11.004_bib0585","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/eje.1.02024","article-title":"Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome","volume":"153","author":"Hahn","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib0590","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ando.2022.11.004_bib0595","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db20-0800","article-title":"Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke","volume":"70","author":"Zhu","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2022.11.004_bib0600","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4239\/wjd.v13.i1.5","article-title":"Polycystic ovary syndrome and type 2 diabetes mellitus: a state-of-the-art review","volume":"13","author":"Livadas","year":"2022","journal-title":"World J Diabetes"},{"key":"10.1016\/j.ando.2022.11.004_bib0605","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2022.11.004_bib0610","doi-asserted-by":"crossref","first-page":"892125","DOI":"10.3389\/fendo.2022.892125","article-title":"The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in chinese population","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.11.004_bib0615","doi-asserted-by":"crossref","first-page":"e1987","DOI":"10.1210\/clinem\/dgab931","article-title":"Novel Lipidomic signature associated with metabolic risk in women with and without polycystic ovary syndrome","volume":"107","author":"Mousa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0620","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cen.14647","article-title":"Natural history of polycystic ovary syndrome: a systematic review of cardiometabolic outcomes from longitudinal cohort studies","volume":"96","author":"Kiconco","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2022.11.004_bib0625","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.fertnstert.2022.03.008","article-title":"Cardiometabolic biomarkers in women with polycystic ovary syndrome","volume":"117","author":"Van der Ham","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2022.11.004_bib0630","first-page":"215","article-title":"Polycystic ovary syndrome and obesity: clinical aspects and nutritional management","volume":"47","author":"Frias-Toral","year":"2022","journal-title":"Minerva Endocrinol (Torino)"},{"key":"10.1016\/j.ando.2022.11.004_bib0635","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2022.11.004_bib0640","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.ando.2022.11.004_bib0645","doi-asserted-by":"crossref","first-page":"e0186136","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2022.11.004_bib0650","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/oby.21651","article-title":"Hepatic steatosis is common in adolescents with obesity and pcos and relates to de novo lipogenesis but not insulin resistance","volume":"24","author":"Cree-Green","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ando.2022.11.004_bib0655","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/10641963.2020.1772815","article-title":"Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS)","volume":"42","author":"\u00d6zkan","year":"2020","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ando.2022.11.004_bib0660","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coemr.2021.01.002","article-title":"Role of obstructive sleep apnea in metabolic risk in PCOS","volume":"17","author":"Sam","year":"2021","journal-title":"Curr Opin Endocr Metab Res"},{"key":"10.1016\/j.ando.2022.11.004_bib0665","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11325-021-02376-2","article-title":"Analysis of the proportion and clinical characteristics of obstructive sleep apnea in women with polycystic ovary syndrome","volume":"26","author":"Yang","year":"2022","journal-title":"Sleep Breath"},{"key":"10.1016\/j.ando.2022.11.004_bib0670","first-page":"e26325","article-title":"Diabetes, polycystic ovarian syndrome, obstructive sleep apnea, and obesity: a systematic review and important emerging themes","volume":"14","author":"Bambhroliya","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2022.11.004_bib0675","article-title":"PCOS and depression: common links and potential targets","author":"Kolhe","year":"2021","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ando.2022.11.004_bib0680","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1017\/S0033291718002076","article-title":"Depression, anxiety and perceived stress in women with and without PCOS: a community-based study","volume":"49","author":"Damone","year":"2019","journal-title":"Psychol Med"},{"key":"10.1016\/j.ando.2022.11.004_bib0685","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/09513590.2019.1650340","article-title":"High level of visfatin and the activation of Akt and ERK1\/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome","volume":"36","author":"Tian","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib0690","doi-asserted-by":"crossref","first-page":"e0271380","DOI":"10.1371\/journal.pone.0271380","article-title":"Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: an omics data based combined approach","volume":"17","author":"Miao","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2022.11.004_bib0695","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/00369330221107099","article-title":"Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis","volume":"67","author":"Li","year":"2022","journal-title":"Scott Med J"},{"key":"10.1016\/j.ando.2022.11.004_bib0700","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000321319","article-title":"Brown versus white adipose tissue: a mini-review","volume":"58","author":"Saely","year":"2012","journal-title":"Gerontology"},{"key":"10.1016\/j.ando.2022.11.004_bib0715","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between adipocyte size and adipokine expression and secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0705","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mmm.2021.01.010","article-title":"Modifications du tissu adipeux au cours du vieillissement","volume":"15","author":"Tropis","year":"2021","journal-title":"M\u00e9decine des Maladies M\u00e9taboliques"},{"key":"10.1016\/j.ando.2022.11.004_bib0710","doi-asserted-by":"crossref","first-page":"406420","DOI":"10.1111\/obr.12646","article-title":"Causes and mechanisms. of adipocyte en-largement and adipose expansion","volume":"19","author":"Haczeyni","year":"2018","journal-title":"Obes Rev"},{"key":"10.1016\/j.ando.2022.11.004_bib0720","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/DMSO.S250699","article-title":"Anti-lipolysis induced by insulin in diverse patho physiologic conditions of adipose tissue","volume":"13","author":"Zhao","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.ando.2022.11.004_bib0725","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ando.2022.11.004_bib0730","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1210\/endo.140.4.6614","article-title":"Leptin modulates the glucocorticoid-induced ovarian steroidogenesis","volume":"140","author":"Barkan","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2022.11.004_bib0735","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/a-1025-3711","article-title":"Several circulating biomarkers for PCOS Di-agnosis","volume":"129","author":"Luo","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2022.11.004_bib0740","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ando.2022.11.004_bib0745","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000453317","article-title":"White adipose tissue and circadian rhythm dysfunc-tions in obesity: pathogenesis and available. therapies","volume":"104","author":"Pagano","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2022.11.004_bib0750","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2017.01.051","article-title":"Testosterone increases CCL-2 expression in visceral adipose tissue from obese women of reproductive age","volume":"444","author":"Crisosto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib0755","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/humupd\/dmab004","article-title":"Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome","volume":"27","author":"de Medeiros","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ando.2022.11.004_bib0760","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/metabo10010032","article-title":"Adipokines and adipose tissue-related metabolites, nuts and cardiovascular disease","volume":"10","author":"Weschenfelder","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.ando.2022.11.004_bib0765","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2022.11.004_bib0770","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2022.11.004_bib0775","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/09513590802234253","article-title":"Body fat composition and distribution in women with polycystic ovary syndrome","volume":"24","author":"Cosar","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib0780","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0785","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary. syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0790","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/deu096","article-title":"Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome","volume":"29","author":"Ezeh","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2022.11.004_bib0795","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/cells11050848","article-title":"Transcriptional and DNA methylation signatures of subcutaneous adipose tissue and adipose-derived stem cells in PCOS women","volume":"11","author":"Divoux","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ando.2022.11.004_bib0800","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2012-2937","article-title":"Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females","volume":"98","author":"Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0805","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/cen.13931","article-title":"Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non-insulin-mediated whole-body glucose uptake","volume":"90","author":"Ezeh","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2022.11.004_bib0810","doi-asserted-by":"crossref","first-page":"e2408","DOI":"10.1210\/clinem\/dgaa235","article-title":"Adipocyte insulin resistance in PCOS: relationship with GLUT-4 expression and whole-body glucose disposal and \u03b2-Cell function","volume":"105","author":"Ezeh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0815","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biochi.2004.11.012","article-title":"Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome","volume":"87","author":"Arner","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.ando.2022.11.004_bib0820","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/humrep\/dey356","article-title":"Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome","volume":"34","author":"Ezeh","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2022.11.004_bib0825","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jc.2017-01958","article-title":"Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome","volume":"103","author":"Kim","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0830","doi-asserted-by":"crossref","first-page":"111137","DOI":"10.1016\/j.mce.2020.111137","article-title":"Developmental programming: adipose depot-specific transcriptional regulation by prenatal testosterone excess in a sheep model of PCOS","volume":"523","author":"Dou","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib0835","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2017.06.026","volume":"108","year":"2017","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.ando.2022.11.004_bib0840","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome\u2013a randomised, double-blind, placebo-controlled trial","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG Int J Obstetr Gynaecol"},{"key":"10.1016\/j.ando.2022.11.004_bib0845","doi-asserted-by":"crossref","first-page":"E1891","DOI":"10.1210\/jc.2013-2227","article-title":"Metformin increases the novel adipokine cartonectin\/CTRP3 in women with polycystic ovary syndrome","volume":"98","author":"Tan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0850","doi-asserted-by":"crossref","first-page":"1253164","DOI":"10.1155\/2020\/1253164","article-title":"Adipose insulin resistance and circulating betatrophin levels in women with PCOS","author":"He","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ando.2022.11.004_bib0855","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2337\/db08-1528","article-title":"Insulin and metformin regulate circulating and adipose tissue chemerin","volume":"58","author":"Tan","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2022.11.004_bib0860","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/db08-0127","article-title":"Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2022.11.004_bib0865","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/EJE-07-0857","article-title":"Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome","volume":"158","author":"Jensterle","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib0870","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12020-021-02934-4","article-title":"Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?","volume":"75","author":"Jensterle","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2022.11.004_bib0875","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists","volume":"105","author":"Cena","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0880","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial","volume":"20","author":"Fr\u00f8ssing","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0885","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40618-021-01666-6","article-title":"The effectiveness and safety of liraglutide in treating overweight\/obese patients with polycystic ovary syndrome: a meta-analysis","volume":"45","author":"Ge","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2022.11.004_bib0890","doi-asserted-by":"crossref","first-page":"170624","DOI":"10.1016\/j.peptides.2021.170624","article-title":"Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats","volume":"145","author":"Wu","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.ando.2022.11.004_bib0895","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","article-title":"Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome","volume":"14","author":"Siamashvili","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ando.2022.11.004_bib0900","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13293-022-00455-x","article-title":"Mitochondrial function and oxidative stress in white adipose tissue in a rat model of PCOS: effect of SGLT2 inhibition","volume":"13","author":"Pruett","year":"2022","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.ando.2022.11.004_bib0905","doi-asserted-by":"crossref","first-page":"830401","DOI":"10.3389\/fendo.2022.830401","article-title":"A meta-analysis of the effect of sodium glucose cotransporter-2 inhibitors on metabolic parameters in patients with polycystic ovary syndrome","volume":"13","author":"Sinha","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.11.004_bib0910","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2022.11.004_bib0915","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ando.2022.11.004_bib0920","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12967-020-02277-0","article-title":"Effects of a ketogenic diet in overweight women with polycystic ovary syndrome","volume":"18","author":"Paoli","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.ando.2022.11.004_bib0925","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.3390\/ijerph182312490","article-title":"Effects of mixed of a ketogenic diet in overweight and obese women with polycystic ovary syndrome","volume":"18","author":"Cincione","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ando.2022.11.004_bib0930","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2022.11.004_bib0935","first-page":"416","article-title":"The importance of brown adipose tissue","volume":"361","author":"Stefan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2022.11.004_bib0940","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2011.00085","article-title":"Uncoupling protein 1 of brown adipocytes, the only uncoupler: a historical perspective","volume":"2","author":"Ricquier","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.11.004_bib0945","doi-asserted-by":"crossref","first-page":"847249","DOI":"10.3389\/fendo.2022.847249","article-title":"Brown adipose tissue and novel management strategies for polycystic ovary syndrome therapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.11.004_bib0950","doi-asserted-by":"crossref","first-page":"651763","DOI":"10.3389\/fendo.2021.651763","article-title":"Brown adipose tissue heterogeneity, energy metabolism, and beyond","volume":"12","author":"Shinde","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.11.004_bib0955","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1210\/jc.2010-0989","article-title":"Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans","volume":"96","author":"Ouellet","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.11.004_bib0960","doi-asserted-by":"crossref","first-page":"108777","DOI":"10.1016\/j.ejrad.2019.108777","article-title":"Characterization of brown adipose tissue (BAT) in polycystic ovary syndrome (PCOS) patients by Z-Spectral Imaging (ZSI)","volume":"123","author":"Li","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ando.2022.11.004_bib0965","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.1992.tb02262.x","article-title":"Postprandial thermogenesis is reduced in polycystic-ovary-syndrome and is associated with increased insulin resistance","volume":"36","author":"Robinson","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib0970","doi-asserted-by":"crossref","first-page":"e98822","DOI":"10.1371\/journal.pone.0098822","article-title":"Supraclavicular skin temperature as a measure of 18F-FDG uptake by BAT in human subjects","volume":"9","author":"Boon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2022.11.004_bib0975","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cen.13913","article-title":"Brown adipose tissue thermogenesis in polycystic ovary syndrome","volume":"90","author":"Shorakae","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2022.11.004_bib0980","doi-asserted-by":"crossref","DOI":"10.1093\/biolre\/ioac125","article-title":"Irisin reduces the abnormal reproductive and metabolic phenotypes of PCOS by regulating the activity of brown adipose tissue in mice","author":"Zheng","year":"2022","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ando.2022.11.004_bib0985","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/a-1157-0615","article-title":"Effects of short term metformin treatment on brown adipose tissue activity and plasma irisin levels in women with polycystic ovary syndrome: a randomized controlled trial","volume":"52","author":"Oliveira","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2022.11.004_bib0990","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1210\/en.2003-0537","article-title":"Direct effects of testosterone, 17 beta-estradiol, and progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for gender-dependent thermogenesis","volume":"144","author":"Monjo","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2022.11.004_bib0995","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/PL00012499","article-title":"Opposite actions of testosterone and progesterone on UCP1 mRNA expression in cultured brown adipocytes","volume":"59","author":"Rodriguez","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ando.2022.11.004_bib1000","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/ijms22010243","article-title":"Androgen reduces mitochondrial respiration in mouse brown adipocytes: a model for disordered energy balance in polycystic ovary syndrome","volume":"22","author":"Lerner","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ando.2022.11.004_bib1005","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/PL00012499","article-title":"Opposite actions of testosterone and progesterone on UCP1 mRNA expression in cultured brown adipocytes","volume":"59","author":"Rodriguez","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ando.2022.11.004_bib1010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/21623945.2020.1870060","article-title":"Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus","volume":"10","author":"Cheng","year":"2021","journal-title":"Adipocyte"},{"key":"10.1016\/j.ando.2022.11.004_bib1015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/21623945.2020.1870060","article-title":"Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus","volume":"10","author":"Cheng","year":"2021","journal-title":"Adipocyte"},{"key":"10.1016\/j.ando.2022.11.004_bib1020","first-page":"312","article-title":"PCOS: Benefits of brown adipose tissue transplantation","volume":"12","author":"Holmes","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib1025","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.1523236113","article-title":"Brown adipose tissue transplantation ameliorates polycystic ovary syndrome","volume":"113","author":"Yuan","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ando.2022.11.004_bib1030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1530\/JOE-20-0068","article-title":"Rat BAT xenotransplantation recovers the fertility and metabolic health of PCOS mice","volume":"248","author":"Du","year":"2021","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib1035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1096\/fj.201600459rr","article-title":"Rutin ameliorates obesity through brown fat activation","volume":"31","author":"Yuan","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.ando.2022.11.004_bib1040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jnutbio.2017.04.012","article-title":"Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat","volume":"47","author":"Hu","year":"2017","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.ando.2022.11.004_bib1045","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15909","article-title":"Brown adipose tissue activation with ginsenoside compound K ameliorates polycystic ovary syndrome","author":"Ye","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ando.2022.11.004_bib1050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/09645284211056663","article-title":"Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota","volume":"40","author":"Zhang","year":"2022","journal-title":"Acupunct Med"},{"key":"10.1016\/j.ando.2022.11.004_bib1055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13020-022-00603-w","article-title":"Three-dimensional visualization of electroacupuncture-induced activation of brown adipose tissue via sympathetic innervation in PCOS rats","volume":"17","author":"Gao","year":"2022","journal-title":"Chin Med"},{"key":"10.1016\/j.ando.2022.11.004_bib1060","doi-asserted-by":"crossref","first-page":"744628","DOI":"10.3389\/fendo.2021.744628","article-title":"Brown Adipose tissue activation by cold treatment ameliorates polycystic ovary syndrome in rat","volume":"12","author":"Ye","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.11.004_bib1065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/JOE-19-0589","article-title":"The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome","volume":"245","author":"Qi","year":"2020","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ando.2022.11.004_bib1070","article-title":"Exercise-induced effects on UCP1 expression in classical brown adipose tissue: a systematic review","volume":"31","author":"Flouris","year":"2017","journal-title":"Horm Mol Biol Clin Investig"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:55:15Z","timestamp":1757717715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426623000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0003426623000021"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2022.11.004","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome and adipose tissue","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}